Andreas Halvorsen’s Amedisys AMED Stock Holding History

Andreas Halvorsen’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-391,131	Closed	-$63.3M	–	95
2021 Q4	$63.3M	Buy	+391,131	New	+$62.9M	0.18%	82

Other funds holding AMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Andreas Halvorsen's AMED Position: Q1 2022 in Review

Andreas Halvorsen sold out of Amedisys (AMED) in Q1 2022, closing a stake of 391,131 shares — an estimated $63.3M sold.

Andreas Halvorsen first reported a position in AMED in Q4 2021 and held it in 1 quarter. The position peaked at $63.3M in Q4 2021. 329 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

Andreas Halvorsen reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
Andreas Halvorsen sold 391,131 Amedisys shares in Q1 2022, an estimated $63.3M.
Andreas Halvorsen first reported a position in Amedisys in Q4 2021 and held it in 1 quarter.
Andreas Halvorsen's Amedisys position peaked at $63.3M in Q4 2021.
329 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on Viking Global Investors's 13F filing for Q1 2022, filed 16 May 2022.